The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Open accessAbstract
Aerobic exercise is associated with decreased cancer incidence and cancer-associated mortality. However, little is known about the effects of exercise on pancreatic ductal adenocarcinoma (PDA), a disease for which current therapeutic options are limited. Herein, we show that aerobic exercise reduces PDA tumor growth, by modulating systemic and intra-tumoral immunity. Mechanistically, exercise promotes immune mobilization and accumulation of tumor-infiltrating IL15Rα+ CD8 T cells, which are responsible for the tumor-protective effects. In clinical samples, an exercise-dependent increase of intra-tumoral CD8 T cells is also observed. Underscoring the translational potential of the interleukin (IL)-15/IL-15Rα axis, IL-15 super-agonist (NIZ985) treatment attenuates tumor growth, prolongs survival, and enhances sensitivity to chemotherapy. Finally, exercise or NIZ985 both sensitize pancreatic tumors to αPD-1, with improved anti-tumor and survival benefits. Collectively, our findings highlight the therapeutic potential of an exercise-oncology axis and identify IL-15 activation as a promising treatment strategy for this deadly disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exercise restrains tumor growth5 and enhances immune checkpoint inhibitor (ICI) efficacy in various preclinical cancer models8–13”
From Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy (2025) · cites this paper as [8]
In the citing paper
“Exercise exerts potent antitumor effects in both preclinical models5,8–13 and cancer patients6.”
From Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy (2025) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C. L., Lao, C. D., Wagstaff, J., Schadendorf, D., Ferrucci, P. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709684 · Cited by 5,357
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Self-citationLa Manno, G., Soldatov, R., Zeisel, A., Braun, E., Hochgerner, H., Petukhov, V., Lidschreiber, K., Kastriti, M. E., Lönnerberg, P., Furlan, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0414-6 · Cited by 4,118
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Lao, C. D., Cowey, C. L., Schadendorf, D., Wagstaff, J., Dummer, R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910836 · Cited by 3,723
Generalizing RNA velocity to transient cell states through dynamical modeling
Bergen, V., Lange, M., Peidli, S., Wolf, F. A., & Theis, F. J. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0591-3 · Cited by 2,951
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
Single-cell mRNA quantification and differential analysis with Census
Qiu, X., Hill, A. J., Packer, J. S., Lin, D., Ma, Y.-A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4150 · Cited by 1,904
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Riquelme, E., Zhang, Y., Zhang, L., Montiel, M., Zoltan, M., Dong, W., Quesada, P., Sahin, I., Chandra, V., San Lucas, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.008 · Cited by 1,577
Self-citation
Cited by
Sorted by citations
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Conroy, T., Pfeiffer, P., Vilgrain, V., Lamarca, Á., Seufferlein, T. T. W., O'Reilly, E. M., Hackert, T., Golan, T., Prager, G. W., Haustermans, K. M., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.08.009 · Cited by 706
Emerging therapies in cancer metabolism
Xiao, Y., Yu, T., Xu, Y., Ding, R., Wang, Y.-P., Jiang, Y., & Shao, Z. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.006 · Cited by 279
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Falcomatà, C., Bärthel, S., Schneider, G., Rad, R., Schmidt‐Supprian, M., & Saur, D. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0876 · Cited by 224
The effect of physical exercise on anticancer immunity
Fiuza‐Luces, C., Valenzuela, P. L., Gálvez, B. G., Ramírez, M. R., López‐Soto, A., Simpson, R. J., & Lucía, A. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00943-0 · Cited by 164
Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression
Huang, Q., Wu, M., Wu, X., Zhang, Y., & Xia, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188761 · Cited by 124
Metabolic interplays between the tumour and the host shape the tumour macroenvironment
Altea‐Manzano, P., Decker-Farrell, A. R., Janowitz, T., & Erez, A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00786-4 · Cited by 138
Wang, K., Ni, B., Xie, Y., Li, Z., Yuan, L., Meng, C., Zhao, T., Gao, S., Huang, C., Wang, H., et al. (2025) · Cell Research · doi:10.1038/s41422-025-01098-4 · Cited by 111
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Liu, S., Sun, Q., & Ren, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01430-8 · Cited by 107
Phelps, C. M., Willis, N. B., Duan, T., Lee, A. H., Zhang, Y., Rodriguez J, D. M., Pandey, S. P., Laughlin, C. R., Rosen, A. B. I., McPherson, A. C., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.018 · Cited by 91
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Wu, H., Fu, M., Wu, M., Cao, Z., Zhang, Q., & Liu, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06930-0 · Cited by 97
Molecular insights of exercise therapy in disease prevention and treatment
Walzik, D., Chirino, T. Y. W., Zimmer, P., & Joisten, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01841-0 · Cited by 95
Research progress of interleukin-15 in cancer immunotherapy
Cai, M., Huang, X., Huang, X., Ju, D., Zhu, Y. Z., & Li, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1184703 · Cited by 83
Zhu, C., Ma, H., He, A., Li, Y., He, C., & Xia, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215814 · Cited by 83
Luo, Z., Mei, J., Wang, X., Wang, R., He, Z., Geffen, Y., Sun, X., Zhang, X., Xu, J., Wan, R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114697 · Cited by 85
Engineering cytokines for cancer immunotherapy: a systematic review
Fu, Y., Tang, R., & Zhao, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1218082 · Cited by 78
Hilmi, M., Delaye, M., Muzzolini, M., Nicolle, R., Cros, J. F., Hammel, P. R., Cardot‐Ruffino, V., & Neuzillet, C. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00207-8 · Cited by 75
Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy
Li, J., Zeng, H., Li, L., Yang, Q., He, L. C., & Dong, M. (2023) · ACS Nano · doi:10.1021/acsnano.3c10212 · Cited by 58
Ngo‐Huang, A., Parker, N. H., Xiao, L., Schadler, K., Petzel, M. Q. B., Prakash, L. R., Kim, M. P., Tzeng, C.-W. D., Lee, J. E., Ikoma, N., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005878 · Cited by 54
Self-citationThe role of myokines in cancer: crosstalk between skeletal muscle and tumor
Park, S.-Y., Hwang, B.-O., & Song, N. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0064 · Cited by 52
Impact of exercise on cancer: mechanistic perspectives and new insights
Ye, F., Feng, X., Wan, R., Luo, Z., Qu, L., & Wang, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474770 · Cited by 59
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 49
Luo, Z., Sun, Y., Xia, W., Xu, J., Xie, D.-J., Jiao, C.-M., Dong, J.-Z., Chen, H., Wan, R., Chen, S., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00474-8 · Cited by 40
Torregrosa, C., Chorin, F., Beltran, E. E. M., Neuzillet, C., & Cardot‐Ruffino, V. (2022) · Cancers · doi:10.3390/cancers14215402 · Cited by 47
Zhao, R., Xiao, Q., Wu, Y., Zhang, W., Liu, J., Zeng, Y., Zhan, J., Cai, Y., & Fang, C. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122453 · Cited by 40
Biskupiak, Z., Ha, V. V., Rohaj, A., & Bulaj, G. W. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020403 · Cited by 45
The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities
Zhang, C., Guo, X., Liu, P., Wang, Y., Zhang, J., Li, L., Wu, K., Xiao, J., Mei, Q., & Wang, Z. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01748-5 · Cited by 43
Vitamin D, exercise, and immune health in athletes: A narrative review
Crescioli, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954994 · Cited by 42
An Overview of Sarcopenia: Focusing on Nutritional Treatment Approaches
Barone, M., Baccaro, P., & Molfino, A. (2025) · Nutrients · doi:10.3390/nu17071237 · Cited by 43
‘Exerkines’: A Comprehensive Term for the Factors Produced in Response to Exercise
Novelli, G., Calcaterra, G., Casciani, F., Pecorelli, S. L., & Mehta, J. L. (2024) · Biomedicines · doi:10.3390/biomedicines12091975 · Cited by 36
Physical activity prevents tumor metastasis through modulation of immune function
Zheng, A., Zhang, L., Yang, J., Yin, X., Zhang, T., Wu, X., & Ma, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1034129 · Cited by 34
Zhang, M., Han, X., Yan, L., Fu, Y., Kou, H., Shang, C., Wang, J., Liu, H., Jiang, C., Wang, J., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14781 · Cited by 32
Physical activity and checkpoint inhibition: association with toxicity and survival
Verheijden, R. J., Ballester, A. C., Smit, K. C., van Eijs, M. J. M., Bruijnen, C. P., van Lindert, A. S. R., Suijkerbuijk, K. P. M., & May, A. M. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad245 · Cited by 33
Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk
Fan, H., Liang, X., & Tang, Y. (2024) · MedComm · doi:10.1002/mco2.784 · Cited by 33
Macrophages on the run: Exercise balances macrophage polarization for improved health
Voskoboynik, Y., McCulloch, A. D., & Sahoo, D. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102058 · Cited by 31
Diet and Exercise in Cancer Metabolism
Locasale, J. W. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0096 · Cited by 29
He, J., Niu, J., Wang, L., Zhang, W., He, X., Zhang, X., Hu, W., Tang, Y., Yang, H., Sun, J., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122475 · Cited by 28
The Influence of Exercise on Cancer Risk, the Tumor Microenvironment and the Treatment of Cancer
He, A., Pu, Y., Jia, C., Wu, M., He, H., & Xia, Y. (2024) · Sports Medicine · doi:10.1007/s40279-024-02031-2 · Cited by 31
Can Exercise Enhance the Efficacy of Checkpoint Inhibition by Modulating Anti-Tumor Immunity?
Brummer, C., Pukrop, T., Wiskemann, J., Bruß, C., Ugele, I., & Renner, K. (2023) · Cancers · doi:10.3390/cancers15184668 · Cited by 26
Role of N6‐methyladenosine RNA modification in cancer
Qu, Y., Gao, N., Zhang, S., Gao, L., He, B., Wang, C., Gong, C., Shi, Q., Li, Z., Yang, S., et al. (2024) · MedComm · doi:10.1002/mco2.715 · Cited by 26
Batatinha, H., Diak, D. M., Niemiro, G. M., Baker, F. L., Smith, K. A., Zúñiga, T. M., Mylabathula, P. L., Seckeler, M. D., Lau, B., LaVoy, E. C. P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1067369 · Cited by 25
Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness
Hapuarachi, B. S., Danson, S. J., Wadsley, J., & Muthana, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1335256 · Cited by 29
Miao, S., Chai, M.-Q., Liu, X.-Y., Wei, C., Zhang, C., Sun, N.-N., Fei, Q.-Z., Peng, L.-L., & Qiu, H. (2024) · BMC Cancer · doi:10.1186/s12885-024-12224-7 · Cited by 25
Liu, P., Chen, S., Gao, X., Liang, H., Sun, D., Shi, B., Zhang, Q., & Guo, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1032907 · Cited by 23
Xu, M., Yu, J., Zhang, C., Xu, C., Wei, X., & Pu, K. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202308362 · Cited by 23
Remodeling the tumor dormancy ecosystem to prevent recurrence and metastasis
Liang, Y., Chen, W., Zhang, Y., & Li, L. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02328-2 · Cited by 29
Farley, M. J., Bartlett, D. B., Skinner, T. L., Schaumberg, M. A., & Jenkins, D. G. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003067 · Cited by 24
Jia, S., Yu, Z., & Bai, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1302769 · Cited by 26
Wan, R., Chen, Y., Feng, X., Luo, Z., Peng, Z., Qi, B., Qin, H., Lin, J., Chen, S., Xu, L., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26604 · Cited by 22
Xue, Y., Xu, P., Hu, Y., Liu, S., Yan, R., Liu, S., Li, Y., Liu, J., Fu, T., & Li, Z. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.02.009 · Cited by 22
Mlynska, A., Dobrovolskienė, N., Žilionytė, K., Lukaseviciute, G., Sagini, K., Martin-Gracia, B., Romero, S., Llorente, A., Linē, A., Butkute, A., et al. (2025) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2025.101041 · Cited by 20
Smith, K. A., Batatinha, H., Niemiro, G. M., Baker, F. L., Zúñiga, T. M., Diak, D. M., Mylabathula, P. L., Kistner, T. M., Davini, D. W., Hoffman, E. A., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.040 · Cited by 20
Gu, X., Cai, L., Luo, Z., Shi, L., Peng, Z., Sun, Y., & Chen, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057088 · Cited by 20
Pita-Grisanti, V., Vélez-Bonet, E., Chasser, K. M., Hurst, Z. A., Liette, A., Vulic, G., Dubay, K., Lahooti, A., Badi, N., Ueltschi, O., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1045 · Cited by 23
The war between the immune system and the tumor - using immune biomarkers as tracers
Yang, K., Lu, R., Mei, J., Cao, K., Zeng, T., Hua, Y., Huang, X., Li, W., & Yin, Y. (2024) · Biomarker Research · doi:10.1186/s40364-024-00599-5 · Cited by 22
Mei, J., Luo, Z., Cai, Y., Wan, R., Qian, Z., Chu, J., Sun, Y., Shi, Y., Jiang, Y., Zhang, Y., et al. (2025) · Research · doi:10.34133/research.0590 · Cited by 19
Tumor-immune-neural circuit disrupts energy homeostasis in cancer cachexia
Shi, X., Arreola, A. X., Zhou, Z., Yang, J., Liu, M., Cai, Y., Ren, Y., Yuan, H., Chen, Q., Chen, X., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.01.014 · Cited by 22
The war on pancreatic cancer: progress and promise
Iacobuzio–Donahue, C. A. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00728-1 · Cited by 18
Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy
Yuan, T., Jia, Q., Zhu, B., Chen, D., & Long, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01145-w · Cited by 20
Crosstalk between Exercise and Immunotherapy: Current Understanding and Future Directions
Liu, J., Liu, W. L., Wan, Y., & Mao, W. (2024) · Research · doi:10.34133/research.0360 · Cited by 18
Farley, M. J., Boytar, A. N., Adlard, K. N., Salisbury, C. E., Hart, N. H., Schaumberg, M. A., Jenkins, D. G., & Skinner, T. L. (2024) · The Journal of Physiology · doi:10.1113/jp286043 · Cited by 20
Exercise intensity governs tumor control in mice with breast cancer
Gomes-Santos, I. L., Kumar, A. S., Hauth, F., Meyer, M. N., Shiferaw, S. Z., Amoozgar, Z., Jain, R. K., & Fukumura, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1339232 · Cited by 17
Acute exercise boosts NAD+ metabolism of human peripheral blood mononuclear cells
Walzik, D., Joisten, N., Schenk, A., Trebing, S., Schaaf, K., Metcalfe, A. J., Spiliopoulou, P., Hiefner, J., McCann, A., Watzl, C., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.004 · Cited by 16
Ma, N., Hua, R., Yang, Y., Liu, Z., Pan, J., Yu, B., Sun, Y., Xie, D., Wang, Y., & Li, Z. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00912-8 · Cited by 18
Cesano, A., Augustin, R. C., Barrea, L., Bedognetti, D., Bruno, T. C., Carturan, A., Hammer, C., Ho, W. S., Kather, J. N., Kirchhoff, T., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-008876 · Cited by 20
Voluntarily wheel running inhibits the growth of CRPC xenograft by inhibiting HMGB1 in mice
Yang, Z., Gao, Y., He, K., Sui, X., Chen, J., Wang, T., Chen, M., Wang, Z., Jiang, Y., & Zhao, L. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112118 · Cited by 17
Inoue, Y., Inui, N., Karayama, M., Asada, K., Fujii, M., Matsuura, S., Uto, T., Hashimoto, D., Matsui, T., Ikeda, M., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03453-z · Cited by 16
Huang, P., Liu, Q., Zhang, T., & Yang, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1380998 · Cited by 16
The investigation of oncolytic viruses in the field of cancer therapy
Yuan, Z., Zhang, Y., Wang, X., Wang, X., Ren, S., He, X., Su, J., Zheng, A., Guo, S., Chen, Y., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1423143 · Cited by 18
Decoding the obesity–cancer connection: lessons from preclinical models of pancreatic adenocarcinoma
Ruiz, C. F., Garcia, C. C., Jacox, J. B., Lawres, L., & Muzumdar, M. D. (2023) · Life Science Alliance · doi:10.26508/lsa.202302228 · Cited by 17
Non-pharmaceutical interventions to optimize cancer immunotherapy
Boesch, M., Baty, F., Rassouli, F., Kowatsch, T., Joerger, M., Früh, M., & Brutsche, M. H. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2255459 · Cited by 15
ERRα fosters running endurance by driving myofiber aerobic transformation and fuel efficiency
Xia, H., Scholtes, C., Dufour, C. R., Guluzian, C., & Giguère, V. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101814 · Cited by 13
Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy
Cascetta, G., Colombo, G., Eremita, G., Garcia, J. G. N., Lenti, M. V., Sabatino, A. D., & Travelli, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1450558 · Cited by 14
Su, Y., & Su, Z. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01852-3 · Cited by 13
Handford, J., Chen, M., Rai, R., Moss, C. L., Enting, D., Peat, N., Karagiannis, S. N., Hemelrijck, M. V., & Russell, B. A. (2022) · Cancers · doi:10.3390/cancers14205039 · Cited by 13
Hjorth, M., Egan, C. L., Telles, G. D., Pál, M., Gallego‐Ortega, D., Fuller, O. K., McLennan, E. D., Gillis, R. D., Oh, T. G., Muscat, G. E. O., et al. (2024) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2024.100991 · Cited by 13
Targeting the immuno-inflammatory-microbial network: a key strategy for sepsis treatment
Xu, Y., Wang, J., Yuan, R. R., Qin, Z., Long, K., & Gao, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1575516 · Cited by 14
Pang, Y., Chen, L., Sun, Q., He, N., Lai, Z., Wang, X., Xie, Z., Yang, W., & Wang, W. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08405-2 · Cited by 12
Molecular origin and biological effects of exercise mimetics
Zhu, Y., & Song, G. (2023) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2023.12.002 · Cited by 14
The dichotomic role of cytokines in aging
Silva, R. C. M. C. (2024) · Biogerontology · doi:10.1007/s10522-024-10152-4 · Cited by 16
Chen, Y., Wang, X., Li, H., Zhang, Z., Gao, Y., Ge, L., Xin, L., Gao, X., Shi, L., Hao, J., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218037 · Cited by 11
The immunology of exercise: Mechanisms, mediators, and therapeutic opportunities
Phelps, C. M., & Meisel, M. (2026) · Immunity · doi:10.1016/j.immuni.2026.04.016 · Cited by 12
Circadian lifestyle determinants of immune checkpoint inhibitor efficacy
Hughes, B. R., Shanaz, S., Ismail-Sutton, S., Wreglesworth, N. I., Subbe, C. P., & Innominato, P. F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1284089 · Cited by 12
Baker, F. L., Smith, K. A., Mylabathula, P. L., Zúñiga, T. M., Diak, D. M., Batatinha, H., Niemiro, G. M., Seckeler, M. D., Pedlar, C. R., O’Connor, D. P., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0570 · Cited by 13
History informing the future of exercise oncology
Galvao, D. A., Courneya, K. S., Lucía, A., May, A. M., Mustian, K. M., Warner, A. B., Joachim, W., Wonders, K. Y., Schmitz, K. H., & Newton, R. U. (2025) · JNCI Monographs · doi:10.1093/jncimonographs/lgaf025 · Cited by 11
Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications
Luo, N., Chen, C., Zhou, W., Hao, J., He, S., Liu, Y., Ku, Y., Huang, L., Zhang, C., Shu, Y., et al. (2025) · MedComm · doi:10.1002/mco2.70387 · Cited by 12
Single-cell sequencing of immune cells after marathon and symptom-limited cardiopulmonary exercise
Yu, Y., Zhang, X., Chen, Y., Li, Y., Bian, S., Yang, Y., Song, H., Zhang, C., Dong, Z., Li, G., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106532 · Cited by 11
Supporting tumor therapy by exercise: boosting T cell immunity by myokines
Gebhardt, K., & Krüger, K. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01116-6 · Cited by 11
Mechanisms Underlying the Rarity of Skeletal Muscle Cancers
Kump, D. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126480 · Cited by 10
The role of inflammatory factors in the tumor microenvironment of pancreatic cancer
Yuan, Y., Zhang, H., Wang, Z., Huang, L., Kabacaoğlu, D., Zhang, B., Song, L., & Ai, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625114 · Cited by 10
Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer
Velasco, M. A. D., Kura, Y., Fujita, K., & Uemura, H. (2024) · International Journal of Urology · doi:10.1111/iju.15378 · Cited by 11
Why is exercise good for you? Scientists are finding answers in our cells
Conroy, G. (2024) · Nature · doi:10.1038/d41586-024-01200-7 · Cited by 9
Association of blood cadmium and physical activity with mortality: A prospective cohort study
Chen, Y., Zhen, C., Zeng, L., Feng, H., Wang, J., Ai, Q. Y. H., Ai, S., Zhang, J., Liang, Y. Y., Xue, H., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117541 · Cited by 9
Schmiechen, Z. C., Nanda, H. A., Burrack, A. L., Hickok, G. H., Butler, J. Z., Cruz-Hinojoza, E., Maurice, N. J., Geuenich, M. J., Yu, C., Tsai, A. K., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0758 · Cited by 9
The Impact and Molecular Mechanisms of Exercise in Cancer Therapy
Sun, Y., Ma, Y., Shi, L., Liu, Y., Dong, Y., & Jin, Q. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47050374 · Cited by 11
Membrane-derived biomimetic nanovesicles in anti-tumor immunotherapy: Advances and outlook
Zhang, X., Jing, H., Wang, Y., Mu, S., Wang, X., Zheng, H., Chen, Y., Wang, K., Sun, J., Bi, J., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.019 · Cited by 11
Metabolic plasticity in pancreatic ductal adenocarcinoma progression and response to treatment
Ma, J., Bhardwaj, V., Lobie, P. E., & Pandey, V. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02620-x · Cited by 10
Behavioral factors to modulate immunotherapy efficacy in cancer
Jongerius, C., Vermeulen, L., van Egmond, M., Evers, A., Buffart, L. M., & Lenos, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1066359 · Cited by 7
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Musiu, C., Lupo, F., Agostini, A., Lionetto, G., Bevere, M., Paiella, S., Carbone, C., Corbo, V., Ugel, S., & Sanctis, F. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341079 · Cited by 9
Kong, W. Y., Soderholm, A. T., Brooks, A. J., Cruz, J. L. G., & Wells, J. W. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102937 · Cited by 9
Ren, T., Ren, Z., Wang, S., & Jing, X. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105729 · Cited by 8
Metadata
- Authors
- Kurz, E., Hirsch, C. A., Dalton, T., Shadaloey, S. A., Khodadadi-Jamayran, A., Miller, G., Pareek, S., Rajaei, H., Mohindroo, C., Baydogan, S., Ngo-Huang, A., Parker, N., Katz, M. H. G., Petzel, M., Vucic, E., McAllister, F., Schadler, K., Winograd, R., & Bar-Sagi, D.
- Affiliations
- New York University (US)
- Columbia University Irving Medical Center (US)
- Trinity Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- Moffitt Cancer Center (US)
- NYU Langone Health (US)
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 40
- Issue
- 7
- Pages
- 720-737.e5
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC9280705
- OpenAlex
- W4282010758
- Cited by
- 258
- References
- 81
- Citations by year
- 2026: 58 · 2025: 69 · 2024: 62 · 2023: 48 · 2022: 21
- FWCI
- 21.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 375 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Prevention and Research Institute of Texas (RP200173)
- National Institutes of Health (CA210263, T32- GM136573, T32CA193111, F30 CA243205)
- Novartis
- National Center for Advancing Translational Sciences
- Stanford Genome Technology Center
- Green Templeton College, University of Oxford
- The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment
- National Cancer Institute (/ NCI 5 P30CA16087, S10 OD021747, NIZ985)
- Canadian Institutes of Health Research (146792, R21CA218732, P30CA016672, R37CA237384\u201301A1, RP170259)
- New York University (T32CA193111, F30 CA243205, T32- GM136573)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Keywords
- aerobic exercise, pancreatic ductal adenocarcinoma, antitumor immunity, CD8+ T cells, tumor-infiltrating lymphocytes, anti-PD-1 therapy, chemosensitivity, exercise oncology
- MeSH terms
- Antineoplastic Agents, Humans, Immunotherapy, Pancreatic Neoplasms, CD8-Positive T-Lymphocytes, Interleukin-15, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Receptors, Interleukin-15, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review